AstraZeneca, Daiichi Sankyo’s Datroway receives FDA approval for TNBC
The FDA granted priority review for Datroway based on results from the TROPION-Breast02 Phase III trial.
26 May 2026
26 May 2026
The FDA granted priority review for Datroway based on results from the TROPION-Breast02 Phase III trial.
Caliway intends to commence both pivotal Phase III trials soon, with clinical results for CBL-0301 and CBL-0302 expected in 2027.
The trial assesses Precem-TcT efficacy and safety alone or with bevacizumab in mCRC patients after previous therapies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.